Pralsetinib
About
Therapy type: Targeted therapy
Therapy strategy: RET inhibition
Mappings
NCI Thesaurus: Pralsetinib (coding:ncit:C132295)
RxNorm: pralsetinib (coding:rxcui:2394936, coding:omop:37002765)
Therapeutic response
Precision oncology relationships for therapeutic response involving this therapy.
Organizations
Biomarkers
Cancer types
Therapies
| Organizations | Biomarkers | Cancer types | Therapies | |
|---|---|---|---|---|
| FDA (2) | v::RET | Non-Small Cell Lung Cancer | Pralsetinib | |
| FDA (2) | v::RET | Papillary Thyroid Cancer | Pralsetinib |